There is a growing interest within the medical community in the use of psychedelic therapies to treat conditions ranging from depression and PTSD to anxiety and eating disorders. New research led by ...
The trial, which is partially funded by $5 million in taxpayer money allocated by the Arizona Legislature and Gov. Katie ...
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback